Ramsay Health Care Limited (OTCMKTS:RMYHY - Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 800 shares, an increase of 60.0% from the March 31st total of 500 shares. Based on an average trading volume of 3,800 shares, the days-to-cover ratio is currently 0.2 days.
Ramsay Health Care Price Performance
Shares of RMYHY stock remained flat at $8.32 on Friday. The stock had a trading volume of 233 shares, compared to its average volume of 1,560. The stock's 50 day simple moving average is $8.38 and its 200-day simple moving average is $8.15. Ramsay Health Care has a one year low of $7.32 and a one year high of $10.98.
Ramsay Health Care Increases Dividend
The firm also recently disclosed a dividend, which was paid on Monday, April 22nd. Investors of record on Tuesday, March 12th were given a $0.0571 dividend. The ex-dividend date of this dividend was Monday, March 11th. This is a positive change from Ramsay Health Care's previous dividend of $0.04.
About Ramsay Health Care
(
Get Free Report)
Ramsay Health Care Limited owns and operates hospitals. The company offers health care services to public and private patients. It operates facilities in approximately 530 locations in the Asia Pacific, the United Kingdom, France, and Nordics. Ramsay Health Care Limited was founded in 1964 and is based in Sydney, Australia.
See Also
Before you consider Ramsay Health Care, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ramsay Health Care wasn't on the list.
While Ramsay Health Care currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
